Streetbeat News

Price Targets

NFLX

JP Morgan analyst Doug Anmuth has reiterated an Overweight rating on Netflix and maintained a $750 price target.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:02 pm

JNJ

Johnson & Johnson (JNJ) has discontinued its Phase 3 SunRISe-2 trial for TAR-200 in combination with cetrelimab for muscle-invasive urothelial carcinoma due to lack of superiority. Despite this, JNJ remains confident in the TARIS platform's potential. The company is set to release its Q3 2024 earnings on October 15, with analysts expecting an EPS of $2.20 and revenue of $22.13 billion. Goldman Sachs has reiterated a Neutral rating, slightly increasing the price target to $162.

Portfolio Pulse from Vandana Singh

October 08, 2024 | 6:00 pm

PENN

Needham analyst Bernie McTernan sees potential growth for PENN Entertainment due to product enhancements and ESPN integration. PENN's Q3 retail operations adjusted EBITDAR is expected to be $465M-$475M, with improved interactive EBITDA guidance. The analyst maintains a Buy rating with a $26 price target.

Portfolio Pulse from Lekha Gupta

October 08, 2024 | 5:59 pm

MBX

JP Morgan has initiated coverage on MBX Biosciences with an Overweight rating and set a price target of $30.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 5:57 pm

WEC

Barclays analyst Eric Beaumont maintains an Underweight rating on WEC Energy Group but raises the price target from $86 to $89.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 5:52 pm

SLM

Barclays analyst Mark Devries has maintained an Overweight rating on SLM Corporation (NASDAQ:SLM) and raised the price target from $23 to $27.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 5:50 pm

PTCT

Baird analyst Joel Beatty has reiterated an Outperform rating for PTC Therapeutics, maintaining a price target of $44.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 5:49 pm

RKT

Barclays analyst Terry Ma maintains an Underweight rating on Rocket Companies (NYSE:RKT) but raises the price target from $10 to $14.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 5:48 pm

RDN

Barclays analyst Mark Devries maintains an Equal-Weight rating on Radian Group (NYSE:RDN) and raises the price target from $32 to $33.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 5:44 pm

PANW

Exane BNP Paribas has initiated coverage on Palo Alto Networks with an Outperform rating and set a price target of $410.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 5:43 pm